Orleans Capital Management’s Core Laboratories CLB Stock Holding History

Orleans Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-9,199	Closed	-$1.35M	–	94
2014 Q3	$1.35M	Sell	9,199 -175	-2%	-$27K	0.66%	63
2014 Q2	$1.57M	Sell	9,374 -92	-1%	-$16.4K	0.73%	64
2014 Q1	$1.88M	Sell	9,466 -42	-0.4%	-$7.93K	0.96%	49
2013 Q4	$1.82M	Buy	9,508 +57	+0.6%	+$10.6K	0.94%	49
2013 Q3	$1.6M	Buy	9,451 +375	+4%	+$58.2K	0.87%	56
2013 Q2	$1.38M	Buy	+9,076	New	+$1.29M	0.78%	62

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Orleans Capital Management's CLB Position: Q4 2014 in Review

Orleans Capital Management sold out of Core Laboratories (CLB) in Q4 2014, closing a stake of 9,199 shares — an estimated $1.35M sold.

Orleans Capital Management first reported a position in CLB in Q2 2013 and held it in 6 quarters. The position peaked at $1.88M in Q1 2014. 345 funds tracked by Wall St. Rank hold CLB as of Q4 2014.

Orleans Capital Management reported no remaining Core Laboratories position as of Q4 2014 after selling out during the quarter.
Orleans Capital Management sold 9,199 Core Laboratories shares in Q4 2014, an estimated $1.35M.
Orleans Capital Management first reported a position in Core Laboratories in Q2 2013 and held it in 6 quarters.
Orleans Capital Management's Core Laboratories position peaked at $1.88M in Q1 2014.
345 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2014.

Based on Orleans Capital Management's 13F filing for Q4 2014, filed 13 Feb 2015.